tetrabutylammonium has been researched along with Myocardial Ischemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, DH; Zhong, B | 1 |
1 other study(ies) available for tetrabutylammonium and Myocardial Ischemia
| Article | Year |
|---|---|
N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1.
Topics: Animals; Benzophenanthridines; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Coronary Circulation; Dopamine; Isoindoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Protein Kinase Inhibitors; Quaternary Ammonium Compounds; Radioimmunoassay; Receptors, Calcitonin Gene-Related Peptide; Receptors, Neurokinin-1; Substance P; TRPV Cation Channels; Ventricular Function, Left; Ventricular Pressure | 2008 |